|
|
||||||||
,



*
Viral and Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333; Departments of
Pathology and
Pharmaceutical Chemistry, University of California, and
Department of Veterans Affairs Medical Center, San Francisco, CA 94121; and
¶ Department of Natural Sciences, Notre Dame de Namur University, Belmont, CA 94002
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
In the U.S., allergic reactions have been associated with T. protracta, T. rubida, T. recurva, T. sanguisuga, T. gerstaekeri, and Paratriatoma hirsuta (6, 7). Allergic sensitization, demonstrated by anti-Triatoma IgE Ab, may develop in as many as 7% of individuals residing within the range of these insects (7). The expansion in both seasonal and perennial human incursions into chaparral or woodland habitats of T. protracta in the western U.S. has increased the number of persons at risk for Triatoma hypersensitivity; it is estimated that as many as 30,000 persons in California are at risk for anaphylaxis from this insect (7).
Isolation of proteins from the saliva of several species of
Triatominae, and characterization of the antihemostatic properties of
these proteins, has been the subject of many recent investigations
(8, 9, 10, 11, 12, 13). However, little is known about the molecular
identity of salivary allergens of these insects. Initial studies with
T. protracta indicate that
89% of the allergenic
activity in the saliva of this bug represents reaction to a 18- to
20-kDa protein (14). We now report the purification of
this major allergenic protein and isolation of a cDNA clone. Successful
expression of recombinant Ag in yeast provides reagent quantities of Ag
for subsequent investigations of the serologic diagnosis, epidemiology,
and desensitization therapy of individuals at risk of severe allergic
reaction to the bite of T. protracta. We also predict the
functional and primary allergenic residues in procalin through sequence
analysis and structural models.
| Materials and Methods |
|---|
|
|
|---|
Paired salivary glands were dissected from 50 fourth-instar T. protracta nymphs and suspended in PBS (pH 7.4). Extracts were filtered through a 0.2-µm cellulose acetate membrane, dialyzed with a 6-kDa cutoff, and initially fractionated by fast protein liquid chromatography on a MonoQ HR5/5 (Pharmacia, Uppsala, Sweden) cationic exchange column. The sample was loaded in 20 mM Tris-HCl (pH 7.4) and eluted with an NaCl gradient (01 M). One-milliliter fractions were collected from a flow rate of 1 ml/min. Three immunologically active fractions were identified by ELISA, using banked serum samples from patients with confirmed allergy to T. protracta (7), and a goat anti-human IgG-HRP conjugate (Boehringer Mannheim, Mannheim, Germany). Sera were obtained from four patients all of whom had at least three life-threatening episodes of anaphylaxis. Ag-containing fractions were purified by using an HPLC system (Rainin Instruments, Emeryville, CA) with a variable wavelength monitor (Knauer, Berlin, Germany). Ag-containing fractions were applied to a C8 peptide reverse-phase column (4.6 x 250 mm; Vydac, Hesperia, CA) in 0.05% trifluoroacetic acid (TFA3; Sigma, St. Louis, MO) and eluted with a 50% methanol/50% water/0.5% TFA gradient (0100% in 30 min). One-milliliter fractions were collected and analyzed by ELISA and SDS-PAGE. The purified 20-kDa Ag was stored at 4°C for 24 h to allow the TFA to evaporate before Edman degradation for N-terminal sequence analysis by using a 470A protein sequencer (Applied Biosystems, Foster City, CA) with an on-line 120A phenylthiohydantoin analyzer (Applied Biosystems).
Isolation and cloning of Triatoma allergen cDNA
A 32-fold degenerate oligonucleotide primer (5'-ACAGAATTCCA(A/G) AA(A/G)CC(T/G)AA(A/G)CC(T/G)ATGGA-3') was deduced from amino acid residues 410 of the amino-terminal sequence of the purified Ag. RNA from two pairs of nymphal T. protracta salivary glands was extracted in RNAzol B (Biotecx Laboratories, Houston, TX) and reverse transcribed by using 400 U Moloney murine leukemia virus reverse transcriptase (Life Technologies, Gaithersburg, MD) and the primer 5'-ACAATCGATAAGCTTTTTTTTTTTTTTTTT-3'. First-strand cDNA was amplified by using PCR. One micromolar of each of the above primers were used in a 50-µl reaction mixture containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 0.2 mM of each dNTP, and 1.25 U Taq DNA polymerase (Boehringer Mannheim). A total of 45 cycles were performed by using a DNA thermal cycler (PerkinElmer Cetus, Norwalk, CT). The first two cycles were performed with annealing at 35°C for 2 min, denaturing at 94°C for 1 min, and extension at 72°C for 2 min. For the subsequent 43 cycles, annealing occurred at 50°C for 2 min, denaturing at 94°C for 1 min, and extension at 72°C for 2 min. The amplified product was gel-purified, electro-eluted in a Spectra/Por molecular porous dialysis membrane (Spectrum Medical Industries, Houston, TX), and subcloned into the EcoRI and HindIII sites of pBluescript (Stratagene, La Jolla, CA). The forward and reverse strands of the recombinant DNA were sequenced by the dideoxy chain termination method using T7 DNA polymerase (United States Biochemical, Cleveland, OH).
A 5' RACE was used to identify the upstream region of the message. First-strand cDNA was again produced by reverse transcription of salivary gland mRNA from two nymphs using 45 pM of a primer designed to the reverse strand at positions 446463 (5'-TTGAAAGAATATAATGCC-3'). The cDNA was treated with 1 U Escherichia coli RNase H (Boehringer Mannheim) and purified in a GlassMAX spin cartridge (Life Technologies). An oligo(dC) anchor sequence was added to the 3' end of the cDNA using 0.4 U TdT (Boehringer Mannheim). The tailed fragment was amplified by using PCR, with 0.4 µM of an oligo(dG) anchor primer (5'-ATAGAATTCGGGGGGGGGGGG-3') and 0.4 µM of a nested primer designed to reverse-strand positions 422438 (5'-ACAAAGCTTCTTGCCAGCATTAGGAC-3'). A 50-µl reaction mixture containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 0.2 mM of each dNTP, and 1.25 U Taq DNA polymerase was amplified for 35 cycles with annealing at 50°C for 2 min, denaturing at 94°C for 1 min, and extension at 72°C for 2 min. The amplified fragment was gel purified, subcloned into the pT7Blue vector (Novagen, Madison, WI), and fully sequenced in both directions.
Expression of procalin cDNA in yeast
A cDNA coding for amino acids 4151 was amplified with primers
to remove the 3' untranslated region and incorporate Xba and
SalI restriction sites at the 5' and 3' ends, respectively.
The resultant fragment was digested with Xba and
SalI and subcloned into the shuttle plasmid pAB125, creating
a fusion gene containing the glucose-repressible alcohol dehydrogenase
2/glyceraldehyde-3-phosphate dehydrogenase promoter at the
factor
leader sequence of Saccharomyces cerevisiae
(15). The expression cassette was digested with
BamHI and SalI and ligated into the yeast
expression plasmid pBS24.1. An overnight culture of the AB 122 strain
of S. cerevisiae carrying the ura3 and leu2 mutations
was grown to OD610 = 1.0. A 45-µl aliquot of
yeast was mixed with 2 µg of pBS 24.1 containing the expression
cassette and transformed by using an Electro Cell Manipulator 600 (BTX,
San Diego, CA) at mode 2.5 kV, resistance 129
, charging voltage 1.0
kV, pulse length 5 ms, and chamber gap 2 mm. Electroporated yeast was
plated onto uracil-deficient SD medium, and transformants were
subsequently transferred to L-leucine-deficient
medium for final selection. Secreted recombinant protein was collected
from the supernatant of yeast cultures grown for 72 h at 30°C in
yeast extract peptone dextrose medium with 1% glucose. Recombinant
protein eluted from a PD10 column equilibrated in 20 mM Tris (pH
7.4), was loaded at 3 ml/min onto a Q Sepharose Fastflow column
(Amersham Pharmacia Biotech, Piscataway, NJ) equilibrated in 20 mM Tris
(pH 7.4). The recombinant protein eluted in the flow through.
Determination of recombinant Ag immunogenicity
Polyclonal antiserum to the recombinant protein was raised in a female New Zealand white rabbit. A primary immunization of 500 µg of purified lyophilized protein in CFA was followed by an i.m. booster injection containing 250 µg protein in IFA at 3 wk. Hyperimmune rabbit serum was harvested at 7 wk. Native salivary gland and recombinant protein samples were run on a 13% SDS-PAGE gel, transferred to a polyvinylidene difluoride membrane, probed with a 1/500 dilution of hyperimmune rabbit serum, washed, and incubated with alkaline phosphatase-linked goat anti-rabbit IgG (1/1000). Ab-labeled proteins were visualized with 5-bromo-4-chloro-3-indoyl-1-phosphate/nitroblue tetrazolium (Promega, Madison, WI).
ELISA with human sera
Recombinant procalin (Tpa-2) was coated onto 96-well polystyrene enzyme immunoassay plates (Costar, Cambridge, MA) at 1 or 10 ng/µl in 50 µl of PBS (0.001 M KH2PO4, 0.01 M Na2HPO4, 0.137 M NaCl, 0.0027 M KCl (pH 7.4)) at 4°C overnight. The wells were rinsed, and then the remaining sites were blocked by incubation at room temperature for 2 h with 100 µl 0.05% Tween 20, 1% BSA in PBS. Serial dilutions of human sera from a known allergic patient (positive toward T. protracta extract) and control human sera were made in blocking buffer (after clearing sera by centrifugation for 4 min at 16,000 x g). Then 50 µl of each dilution was incubated with the recombinant Tpa-2-coated wells for 1 h at room temperature. The rinsed wells were then incubated for 1 h at room temperature with 100 µl of an alkaline phosphatase-labeled secondary Ab to human IgGs, IgM made in goat (Zymed, South San Francisco, CA) at either 1/500 or 1/2000 dilution (in blocking buffer). The rinsed wells were then incubated 30 min at room temperature with alkaline phosphatase substrate (p-nitrophenylphosphate; Zymed), and the absorbance was measured in a spectrophotometric plate reader at 405 nm (Vmax; Molecular Devices, Menlo Park, CA).
Immunolocalization of salivary Ag of T. protracta
Immunohistochemical staining was performed using both intact T. protracta and separately dissected salivary glands. Whole bugs or isolated salivary glands were fixed in 8% paraformaldehyde-0.1 M phosphate buffer (pH 7.4) for 24 h, dehydrated, and embedded in methacrylate plastic (16). The entire procedure was conducted at 4°C. Sections (2.5 µm) were cut and incubated overnight at 4°C with a 1/1000 dilution of hyperimmune rabbit antiserum reactive with the recombinant protein, which were washed and incubated with a 1/100 dilution of alkaline phosphatase-labeled goat anti-rabbit Ab by using the Vectastain ABC (avidin-biotin complex)-alkaline phosphatase kit (Vector Laboratories, Burlingame CA) (17, 18).
| Results |
|---|
|
|
|---|
Fig. 1
shows fractionation of the
salivary gland proteins by MonoQ ion-exchange and HPLC CC8
chromatography as monitored by ELISA using pooled serum samples from
patients with allergy to T. protracta. A single 20-kDa
protein band corresponded to the purified allergen as identified by
ELISA. Amino-terminal sequencing of this 20-kDa salivary gland Ag
tentatively determined amino acid residues 120 as
DE(?)(Q/E)(N/K)P(E/K)PM(Q/E)GFSATQF (H/Y)(K/Q)G. A 32-fold degenerate
oligonucleotide primer corresponding to positions 410 (QKPKPME)
was used in conjunction with an oligo(dT) primer to amplify a single
DNA fragment of 517 bp from reverse-transcribed, polyadenylated RNA
isolated from the salivary glands of T. protracta. This
fragment was subcloned and sequenced, revealing an open reading frame
encoding 138 aa downstream from the 410 primer. Primers were deduced
from the internal sequence of the cloned fragment and used in a 5' RACE
reaction to obtain the upstream region of the gene encoding the signal
peptide and the first 10 amino acids of the sequenced protein.
|
19 kDa. The partial amino acid sequence of the
amino terminus obtained from Edman analysis matches the sequence
predicted by the cDNA clone, except for a blank cycle produced by a
cysteine in position 3 and the misidentification of threonine for
serine in position 15. A hydrophobic 18-residue signal peptide sequence
precedes the mature protein, with a predicted cleavage site
corresponding to the site determined by N-terminal sequencing
(19). The nucleotides preceding the start codon match the
translation initiation sequence (A/C)AA(A/C)ATG described for other
orders of Insecta (20), including genes for salivary gland
proteins of hematophagous Diptera (21, 22) and Hemiptera
(10, 12). No asparagine-linked glycosylation sites are
identified. Comparison of the sequences produced by RT-PCR and by 5'
RACE reveals nucleotide ambiguities at seven positions, resulting in
six amino acid substitutions.
|
The combination of secondary structure predictions and threading
results indicate that procalin is a lipocalin. PhD predicts that
procalin is composed of eight extended
strands and a helix at the C
terminus, a motif consistent with the lipocalin superfamily. Threading
template structures that yield statistically significant matches to
procalin are all lipocalins. From the diverse 123D database containing
1101 domains, only three structures (bilin binding protein (1bbpA),
retinol binding protein (1aqb), and
-lactoglobulin (1bebA)) match
with significant statistical weight. All three are lipocalins. Similar
results are obtained from the hybrid threading algorithm of Fischer,
with the lipocalin triabin as the highest scoring threaded structure by
a large margin.
The best aligned sequence with procalin comes from an isoform of the salivary platelet aggregation inhibitor from R. prolixus. This sequence has no known structure from which a model can be constructed. The second highest match was to the triabin precursor sequence. Triabin, but not its precursor, has been solved crystallographically (25). The pro domain of triabin and procalin are nearly identical and hence the active solution form of procalin likely is homologous to triabin.
Expression of recombinant protein in yeast
Secreted recombinant Ag (procalin) was collected for 72 h at
30°C in yeast extract peptone dextrose medium with 1% glucose,
yielding 3.8 mg/100 ml culture medium after purification (Fig. 3
). The recombinant protein was
transferred by immunoblotting to polyvinylidene difluoride membranes
(Problott) from 16% SDS-PAGE (see above), and gas-phase
sequencing revealed the amino-terminal sequence of the recombinant
protein to be (?)PEPMQGF, consistent with the expected product.
Immunoblot analysis using antisera raised against recombinant procalin
confirmed a cross-reactivity with the native salivary gland allergen
(Fig. 4
A). Furthermore, serum
from a highly allergic patient reacted with recombinant procalin on
ELISA (Fig. 4
B).
|
|
Fig. 5
shows immunohistochemical
localization of procalin to the salivary glands of T.
protracta using rabbit antiserum produced against purified
recombinant procalin. Intense immunostaining was localized to the
cytoplasm of simple cuboidal epithelium of the principle and accessory
salivary glands (26) and to the luminal contents of
the glands. Positive staining was confined to the salivary gland
tissues and secretions of the insect and was not identified in any
other tissue.
|
| Discussion |
|---|
|
|
|---|
The protein allergen predicted from the cDNA clone shows homology to
members the lipocalin family of proteins. Amino acid sequence identity
among lipocalins is characteristically low, often as low as 1020%.
However, crystallographic analyses of several members of this protein
family reveals a remarkably conserved three-dimensional structure:
eight antiparallel
-strands that form a cup-shaped barrel around an
internal ligand-binding site (23). This family is
characterized by a heterogeneous group of small-secreted proteins with
high affinity and selectivity for hydrophobic ligands. In this
capacity, lipocalins may function in the extracellular transport of
insoluble lipophilic molecules including retinoids, steroids, and small
metabolites (27). Some lipocalins are reported to bind
to specific cell surface receptors and may be directly involved in
cell regulation (23, 24) or synthetic pathways of PGs
(28). Although the biologic functions of procalin, the
19-kDa salivary protein of T. protracta, are not
specifically known, lipocalin-based proteins with distinct
antihemostatic properties have been isolated from the salivary glands
of related species of triatomine bugs, including T.
pallidipenis and R. prolixus (25, 29).
Both structural and sequential alignment methods predict that procalin
is similar to triabin, an exosite thrombin inhibitor and procalin
(12).
Several major allergens of animals and other insects have also recently
been identified as lipocalins (30). These include urinary
protein allergens of rodents, the canine allergens CANF1 and CANF2, the
food allergen
-lactoglobulin, the bovine allergen BOSD5, and a
cockroach allergen. As triggers of intermediate-type hypersensitivity
reactions, lipocalins are known to bind IgE both in vitro and in vivo.
T cell epitopes identified in the bovine lipocalin allergen have been
shown to colocalize with conserved amino acid sequence motifs of the
lipocalin family (30). The alignment of sequences at the C
termini of Bos d 2 and procalin yielded a plausible prediction of the
major epitope in procalin. The C-terminal region of both Bos d 2 and
procalin have fairly high sequence homology, with residues at the very
center of the putative allergenic site in procalin identical with the
center of the known allergenic site in Bos d 2. In addition, the
putative epitope in procalin shares a chemical signature with other
allergens in the lipocalin family. In Bos d 2 and Bos d 5
(31), there appears to be a motif near the most allergenic
regions that starts with a proline, followed by a few polar or
positively charged amino acids, immediately before an isolated stretch
of one to three hydrophobic residues, followed by another stretch of
polar and charged residues ending with either a lysine or arginine.
Every known allergen in the lipocalin family (32) has this
motif within its sequence, although the motifs location relative to
the C terminus varies considerably. Procalins putative C terminus
epitope also contains this motif (residues 130139).
At least two different polymorphisms exist for the 19-kDa salivary Ag gene. Because mRNAs used to obtain these sequences were obtained from multiple bugs, it is not known whether these polymorphisms reflect multiple alleles within one insect or genetic heterogeneity among the insects from which the salivary glands were collected. Minor polymorphisms have also been observed among cDNA clones of other recently identified salivary proteins of triatomine bugs, including pallidipin (10) and triabin (12).
Isolation of a full-length cDNA coding for a 19-kDa salivary allergen of T. protracta allowed the subsequent heterologous expression of a recombinant protein (procalin) in S. cerevisiae. The vector chosen to express the allergen is a prototype of the S. cerevisiae expression vectors used for commercial production of hepatitis B Ag and other clinically useful protein reagents (22). The allergen is expressed as a nonfusion protein at 38 mg/L yeast culture.
Using purified recombinant protein, specific polyclonal antiserum was produced in rabbits and used to confirm the location of the allergen in the salivary gland cells and saliva of T. protracta. The antiserum also recognized the corresponding native allergen in T. protracta extracts and the recombinant protein was in turn recognized by serum from an allergic individual. Expression and purification of this recombinant allergen provides reagent quantities of protein for future use in serologic testing to identify individuals at risk for hypersensitivity to the bite of this insect. Further studies will determine whether recombinant procalin may also be used to desensitize persons with severe allergy to T. protracta.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. James H. McKerrow, Department of Pathology, University of California, Box 0506, San Francisco, CA 94143. E-mail address: jmck{at}cgl.ucsf.edu ![]()
3 Abbreviations used in this paper: TFA, trifluoroacetic acid; BLAST, basic local alignment search tool. ![]()
Received for publication November 22, 2000. Accepted for publication June 20, 2001.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Saarelainen, T. Zeiler, J. Rautiainen, A. Narvanen, M. Rytkonen-Nissinen, R. Mantyjarvi, P. Vilja, and T. Virtanen Lipocalin allergen Bos d 2 is a weak immunogen Int. Immunol., April 1, 2002; 14(4): 401 - 409. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |